States file third suit against generics industry
A coalition of 51 US states and territories have filed their third sweeping antitrust lawsuit against the generic pharmaceuticals industry, alleging a massive conspiracy to fix prices for topical skin treatments.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is a leading global provider of competition law, regulation and enforcement information, combining data, deep market insight and a user-centric platform to provide our clients with powerful legal solutions.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10